ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine
Clinical trial NCT05752201 · COMPLETED
Trial details
- NCT number
- NCT05752201
- Sponsor
- Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-06
- Primary completion
- 2023-08-22
- Enrollment
- 2014
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.